At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
biopsyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Human Papillomatosis Genotyping and Severity in Patients With Recurrent Respiratory Papillomatosis of Children in Thailand
Queen Sirikit National Institute of Child Health·observational·Posted Feb 28, 2011·Updated Feb 17, 2014
In Brief
An observational study evaluating biopsy for Recurrent Laryngeal Papillomatosis and Human Papilloma Virus. Completed, enrolled 15 participants across 2 sites.
Detailed Summary
The purpose of the present study was to identify risk factors for more severe juvenile Recurrent Respiratory Papillomatosis (RRP) through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity using above mentioned staging system at the time of each endoscopic debridement, as well as human papilloma virus (HPV) genotyping.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesThailand
CollaboratorsMerck Sharp & Dohme LLC
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2011
Enrollment StartMar 2011
Primary CompletionSep 2012
Study CompletionDec 2012
TodayJul 2026
First PostedFeb 28, 2011
Enrollment StartMar 1, 2011
Primary CompletionSep 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 15.3 years ago
Interventions
biopsyprocedure
excisional biopsy